Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001780854-26-000002

Chief Commercial Ofc Imm Med acquired 39,063 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BENZENO SHARON · Chief Commercial Ofc Imm Med

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2026-03-04 Grant or award : show line 1 in the form +39,063 335,854 D
Loading xslF345X05/form4.xml…